N03AG01
PolandValproic acid
-
Absenor
Form: tablets, prolonged release
Active substance Dosage sodium valproate 300 mg ATC code: N03AG01
Manufacturer: Orion Corporation
-
Absenor
Form: tablets, prolonged release
Active substance Dosage Sodium valproate 500 mg ATC code: N03AG01
Manufacturer: Orion Corporation
-
Convival chrono
Form: tablets, prolonged release
Active substance Dosage sodium valproate 300 mg ATC code: N03AG01
Manufacturer: G.L. Pharma GmbH
-
Convulex
Form: capsules, soft gelatin
Active substance Dosage valproic acid 500 mg ATC code: N03AG01
Manufacturer: G.L. Pharma GmbH
-
Convulex
Form: syrup
Active substance Dosage Sodium valproate 50 mg/ml Valproic acid 4.338 g Sodium chloride 0.04 g ATC code: N03AG01
Manufacturer: G.L. Pharma GmbH
-
Convulex 150
Form: capsules, soft gelatin
Active substance Dosage valproic acid 150 mg ATC code: N03AG01
Manufacturer: G.L. Pharma GmbH
-
Convulex 300
Form: capsules, soft gelatin
Active substance Dosage valproic acid 300 mg ATC code: N03AG01
Manufacturer: G.L. Pharma GmbH
-
Depakin
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage sodium valproate 400 mg/4 ml ATC code: N03AG01
Manufacturer: Sanofi Belgium
-
Depakine
Form: syrup
Active substance Dosage Sodium valproate 5.764 g ATC code: N03AG01
Manufacturer: Sanofi Winthrop Industrie Unither Liquid Manufacturing
-
Depakine
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage sodium valproate 400 mg ATC code: N03AG01
Manufacturer: Sanofi Winthrop Industry
-
Depakine
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage sodium valproate 400 mg ATC code: N03AG01
Manufacturer: Sanofi Winthrop Industry
-
Depakine
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage sodium valproate 400 mg ATC code: N03AG01
Manufacturer: Sanofi s.r.o.
-
Depakine
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage Sodium valproate 400 mg ATC code: N03AG01
Manufacturer: Sanofi Winthrop Industry
-
Depakine chrono 300
Form: tablets, film-coated, prolonged release
Active substance Dosage sodium valproate 200 mg valproic acid 87 mg ATC code: N03AG01
Manufacturer: Sanofi Aventis S.A. Sanofi Winthrop Industry
-
Depakine chrono 500
Form: tablets, film-coated, prolonged release
Active substance Dosage Sodium valproate 333 mg Valproic acid 145 mg ATC code: N03AG01
Manufacturer: Sanofi-aventis Monoprósopi S.A.
-
Depakine chrono 500 mg
Form: tablets, film-coated, prolonged release
Active substance Dosage Sodium valproate 333 mg Valproic acid 145 mg ATC code: N03AG01
Manufacturer: Sanofi-aventis Monoprósopi S.A.
-
Depakine chronosphere 100
Form: granules, prolonged release
Active substance Dosage Sodium valproate 66.66 mg Valproic acid 29.03 mg ATC code: N03AG01
Manufacturer: Sanofi Winthrop Industry
-
Depakine chronosphere 1000
Form: granules, prolonged release
Active substance Dosage sodium valproate 666.6 mg valproic acid 290.27 mg ATC code: N03AG01
Manufacturer: Sanofi Winthrop Industry
-
Depakine chronosphere 250
Form: granules, prolonged release
Active substance Dosage Sodium valproate 166.76 mg Valproic acid 72.61 mg ATC code: N03AG01
Manufacturer: Sanofi Winthrop Industry
-
Depakine chronosphere 500
Form: granules, prolonged release
Active substance Dosage Sodium valproate 333.3 mg Valproic acid 145.14 mg ATC code: N03AG01
Manufacturer: Sanofi Winthrop Industry
-
Depakine chronosphere 750
Form: granules, prolonged release
Active substance Dosage Sodium valproate 500.06 mg Valproic acid 217.75 mg ATC code: N03AG01
Manufacturer: Sanofi Winthrop Industry
-
Valpro lek 500
Form: tablets, prolonged release
Active substance Dosage valproic acid No input provided sodium valproate No input provided ATC code: N03AG01
Manufacturer: HEXAL A/S Lek Pharmaceuticals d.d. LEK S.A. Salutas Pharma GmbH
-
Valprolek 300
Form: tablets, prolonged release
Active substance Dosage valproic acid No input provided sodium valproate No input provided ATC code: N03AG01
Manufacturer: HEXAL A/S Lek Pharmaceuticals d.d. LEK S.A. Salutas Pharma GmbH